Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.808177
Title: Elucidation of novel factors driving inflammation and pancreatic beta-cell death in type 2 diabetes
Author: López, Laura
Awarding Body: Nottingham Trent University
Current Institution: Nottingham Trent University
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Type 2 diabetes (T2D) is a chronic metabolic disorder where failure to maintain normal glucose homeostasis is associated with, and exacerbated by, obesity and the concomitant elevated free fatty acid (FFA) concentrations typically found in these patients (Olokoba et al 2012). 463 million people are currently estimated to be living with diabetes, of which 229 million are undiagnosed. Importantly, around 90% of all cases are T2D cases. Hyperglycaemia and hyperlipidaemia together contribute to a decline in pancreatic insulin-producing beta cell (β-cell) mass through activation of pro-inflammatory signalling pathways. Glucolipotoxicity (GLT) is the term given to the combined and damaging effect of increased glucose and FA levels on pancreatic β-cells (Poitout et al 2010). There are however a large number of molecules potentially able to modulate these pro inflammatory pathways, and the mechanism(s) by which GLT induces inflammation remains poorly defined. Utilising Illumina HiSeq next generation sequencing technology, I have analysed the β-cell transcriptome to identify those genes and proteins most sensitive to high glucose and FA environment. Data shows that of those molecules potentially able to activate inflammatory pathways, the S100 family of proteins are amongst the most highly upregulated by GLT. Independent PCR and immunoblot analysis have further confirmed upregulation of the three most highly expressed family members, namely S100A3, A4 and A5. Importantly, my data has established a link between S100A4 and NF-κB activation that is driven by glucose and FAs. In order to determine wider mechanisms involved in the activation of NF-κB by S100A4, predictive pathway interaction maps have been generated for S100A4 based on the RNAseq data. This approach has uncovered a potentially novel interaction with a pro inflammatory transcription factor not previously associated with T2D, HIF-1α, thereby establishing a link between inflammation and hypoxia, and by extent, between T2D and cancer. This provides a valuable strategy that can be further exploited to discover novel potential targets for therapeutic intervention in the treatment of T2D.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.808177  DOI: Not available
Share: